You’re Invited: Beacon World Tour at a city near you! Learn More

Research Area

Bruker Cellular Analysis' precision development and pathway monitoring are advancing targeting in Oncology

Use true functional immune cell biology to reveal biomarkers for autoimmunity and immune-related adverse events.

Discover sources of resistance to Cancer Signaling Pathway therapies by understanding single-cell pathways that translate to therapeutic insights

Bruker Cellular Analysis detects the key intracellular pathways in tumor cells that can uncover critical and unseen targets in oncology, helping you understand earlier in development the impacts of your therapies, and also mechanisms behind patient resistance in oncology research.

Cancer Resistance Revealed Through the Single Cell Intracellular Proteome, Masked Through Bulk and Genomics

Webinars & Interviews

See how industry leaders and pioneers are revealing the true functional biology to accelerate research and medicine

Speaker: Arnold Levine, PhD, Professor Emeritus, Simons Center for Systems Biology, Institute for Advanced Study
Speaker: Denis Wirtz, PhD, Vice Provost for Research, Chemical & Biomolecular Engineering, Pathology, Oncology Director, Johns Hopkins Physical Sciences-Oncology Center Johns Hopkins University and Johns Hopkins School of Medicine
Speaker: Rui Zheng, PhD, VP of Innovations, Bruker Cellular Analysis
Bruker Cellular Analysis' Functional Cell Biology Has Been Published in 100+ Publications

Case Studies and Resources

Stay at the cutting edge of science and medicine with case studies, literature and resources

App Note
Proteomic Barcoding Product Suite for Oncology & Tumor Functional Phenotyping